FDA Permanently Bans Convicted Drug Developer Bernardo Garmendia
Published Date: 3/14/2025
Notice
Summary
Bernardo Garmendia tried to fight the FDA’s decision to ban him, but the FDA said no hearing for you! He’s now permanently banned from working with any drug companies because he was convicted of a serious crime related to drug approval. This ban is official and starts now, meaning no more drug-related work for Garmendia ever again.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Permanent ban from drug-industry work
The FDA has permanently debarred Bernardo Garmendia from providing services in any capacity to any person that has an approved or pending drug product application under the Federal Food, Drug, and Cosmetic Act. The Agency denied his request for a hearing because he failed to submit information sufficient to create a basis for a hearing, and the debarment is based on his federal felony conviction related to drug development or approval.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16959, Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Frequently asked Questions--Developing Potential Cellular and Gene Therapy Products." The guidance document provides industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy (CGT) products. The FAQs represent common questions directed to the Agency and span multiple disciplines, including regulatory review; chemistry, manufacturing, and controls (CMC); pharmacology/toxicology; clinical; and clinical pharmacology. This guidance announced in this notice finalizes the draft guidance of the same title issued on November 19, 2024.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
Previous / Next Documents
Previous: 2025-04116, Determination: Foreign Affairs Functions of the United States
The U.S. Secretary of State is leading a strong effort to protect America by controlling who and what crosses our borders. This means tighter rules on visas, exports, and travel to keep out threats like spies, drugs, and illegal migration. These changes affect many federal agencies and aim to keep Americans safe without extra costs or delays.
Next: 2025-04118, Mid-Atlantic Fishery Management Council (MAFMC); Public Meetings
The Mid-Atlantic Fishery Management Council is hosting public meetings soon, including a special joint session with the Atlantic States Marine Fisheries Commission. These meetings affect fishermen, seafood businesses, and anyone interested in managing fish in the Mid-Atlantic waters. It’s a chance to learn about new rules, share your thoughts, and stay updated on fishery plans that could impact the local economy and environment.